ArticleEuropean journal of medical research2025
The effectiveness of hydrogel matrix containing nitric oxide, silver nanoparticles, vancomycin, and ciprofloxacin on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa biofilm isolated from patients with chronic rhinosinusitis.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundMany scientists are studying chronic rhinosinusitis (CRS) due to its high relapse incidence and drug resistance. We investigated the antibiofilm activity and sustained co-release of nitric oxide, silver nanoparticles, vancomycin, and ciprofloxacin in thermosensitive hydrogel (HyNSVC) for bacterial CRS.
methodsTo identify and isolate Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA), samples were taken from 10 patients with CRS who underwent Functional Endoscopic Sinus Surgery (FESS), and then they were diagnosed using culture and molecular methods. The HyNSVC was synthesized, and its physicochemical characteristics were evaluated using different methods. The broth microdilution assay and the MTP (microtiter plate) method assessed the minimum inhibitory concentration (MIC) and antibiofilm effects. The inhibitory impact of HyNSVC on the expression of biofilm-associated genes was evaluated using real-time PCR. The cytotoxic effect of HyNSVC on the human epithelial cell line A549 was assessed.
resultsThe results of the SEM showed that the hydrogels have a porous structure and that the pores are interconnected. The molecular weights and polydispersity index (PDI) of the copolymer determined using gel permeation chromatography (GPC) were 5759 Daltons, 6270 Daltons, and 1.089, respectively. The anticipated molecular weight determined by H-NMR spectroscopy was around 5947 Daltons. Also, the porosity of the hydrogels was in the range of 80-90%. The HyNSVC MIC was 250 µg/ml for both bacteria. The 2 × MIC of HyNSVC reduced mature biofilm by 62% in P. aeruginosa and 68.1% in MRSA. The presence of HyNSVC did not significantly reduce gene expression. Finally, the MTT experiment showed no toxicity against A549 cells at the MIC concentration.
conclusionOur findings illustrated the efficacy of employing HyNSVC for drug release regulation and antibiofilm activity for bacterial infection, suggesting a promising treatment for CRS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.